Literature DB >> 7268211

Cimetidine: a specific inhibitor of hepatic aryl hydrocarbon hydroxylase (AHH) in the rat.

R Drew, J Rowell, J J Grygiel.   

Abstract

Aryl hydrocarbon hydroxylase was selectively inhibited in hepatic microsomes prepared 2 hours after administration of cimetidine (150 mg/kg, i.p.) to male Wistar rats. Cytochrome P-450 content and other mixed function oxidase activities were not affected. In rats pretreated with phenobarbital or 3-methylcholanthrene, cimetidine caused a 50% and 90% reduction or aryl hydrocarbon hydroxylase activity respectively, compared to 70% inhibition in uninduced animals. Chronic administration of cimetidine (150 mg/kg, b.i.d. for 5 days) to uninduced rats resulted in 70% inhibition of aryl hydrocarbon hydroxylase but no change in other microsomal enzyme activities. Hexobarbital sleeping time was markedly prolonged 30 min after a single dose of cimetidine but had returned to control values after 24 hrs. Similar effects were observed with chronic dosing of cimetidine. It is concluded that in vivo administration of cimetidine is a relatively specific inhibitor of hepatic aryl hydrocarbon hydroxylase in the rat, and that cimetidine does not induce the microsomal mixed function oxidase system when administered chronically.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7268211

Source DB:  PubMed          Journal:  Res Commun Chem Pathol Pharmacol        ISSN: 0034-5164


  3 in total

1.  Drug interactions through binding to cytochrome p 450: the experience with h2-receptor blocking agents.

Authors:  U Klotz; I W Reimann
Journal:  Pharm Res       Date:  1984-03       Impact factor: 4.200

2.  Differential effects of cimetidine on theophylline metabolic pathways.

Authors:  J J Grygiel; J O Miners; R Drew; D J Birkett
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

3.  Effects of enoxacin on renal and metabolic clearance of theophylline in rats.

Authors:  M Nadai; T Hasegawa; T Kuzuya; I Muraoka; K Takagi; H Yoshizumi
Journal:  Antimicrob Agents Chemother       Date:  1990-09       Impact factor: 5.191

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.